Earnings Feed
Start Free
Home/Filings/4/0001415889-18-001318
4//SEC Filing

GIN JERRY B 4

Accession 0001415889-18-001318

CIK 0001411685other
View on SEC.govCompany Profile

Filed

Aug 30, 8:00 PM ET

Accepted

Aug 31, 5:24 PM ET

Size

21.2 KB

Accession

0001415889-18-001318

Insider Transaction Report

Form 4
Period: 2018-08-29
VistaGen Therapeutics, Inc.VTGN
GIN JERRY B
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-08-29+35,000→ 35,000 total
    Exercise: $1.50Exp: 2026-11-09→ Common Stock (35,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-08-29+25,000→ 25,000 total
    Exercise: $1.50Exp: 2026-06-19→ Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-08-29+25,000→ 25,000 total
    Exercise: $1.50Exp: 2026-11-09→ Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-08-29+25,000→ 25,000 total
    Exercise: $1.50From: 2018-08-29Exp: 2026-03-30→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-08-29−25,000→ 0 total
    Exercise: $8.00From: 2017-03-30Exp: 2026-03-30→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-08-29−25,000→ 0 total
    Exercise: $3.49Exp: 2026-06-19→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-08-29−25,000→ 0 total
    Exercise: $3.80Exp: 2026-11-09→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-08-29−35,000→ 0 total
    Exercise: $1.96Exp: 2026-11-09→ Common Stock (35,000 underlying)
Footnotes (7)
  • [F1]The reporting person agreed to cancellation of an option granted to him on 3/30/2016 in exchange for a new option having a lower exercise price.
  • [F2]The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price.
  • [F3]The option vests monthly over a period of four years commencing 6/19/2016.
  • [F4]The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price.
  • [F5]The option vests monthly over a period of three years commencing 11/9/2016.
  • [F6]The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price.
  • [F7]The option vests monthly over a period of three years commencing 4/26/2017.

Documents

1 file

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

→
Entity typeother

Related Parties

1
  • filerCIK 0000901014

Filing Metadata

Form type
4
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 5:24 PM ET
Size
21.2 KB
View on SEC.gov